LSV Asset Management’s Myriad Genetics MYGN Stock Holding History

LSV Asset Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-696,600	Closed	-$26.1M	–	1016
2015 Q3	$26.1M	Sell	696,600 -67,230	-9%	-$2.39M	0.06%	250
2015 Q2	$26M	Sell	763,830 -12,000	-2%	-$408K	0.05%	247
2015 Q1	$27.5M	Sell	775,830 -13,700	-2%	-$490K	0.06%	236
2014 Q4	$26.9M	Sell	789,530 -61,200	-7%	-$2.17M	0.06%	238
2014 Q3	$32.8M	Sell	850,730 -15,500	-2%	-$578K	0.07%	213
2014 Q2	$33.7M	Sell	866,230 -16,500	-2%	-$614K	0.07%	208
2014 Q1	$30.2M	Sell	882,730 -73,900	-8%	-$2.29M	0.07%	206
2013 Q4	$20.1M	Buy	956,630 +950,830	+16,394%	+$24M	0.05%	259
2013 Q3	$136K	Buy	+5,800	New	+$165K	﹤0.01%	901

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

LSV Asset Management's MYGN Position: Q4 2015 in Review

LSV Asset Management sold out of Myriad Genetics (MYGN) in Q4 2015, closing a stake of 696,600 shares — an estimated $26.1M sold.

LSV Asset Management first reported a position in MYGN in Q3 2013 and held it in 9 quarters. The position peaked at $33.7M in Q2 2014. 232 funds tracked by Wall St. Rank hold MYGN as of Q4 2015.

LSV Asset Management reported no remaining Myriad Genetics position as of Q4 2015 after selling out during the quarter.
LSV Asset Management sold 696,600 Myriad Genetics shares in Q4 2015, an estimated $26.1M.
LSV Asset Management first reported a position in Myriad Genetics in Q3 2013 and held it in 9 quarters.
LSV Asset Management's Myriad Genetics position peaked at $33.7M in Q2 2014.
232 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2015.

Based on LSV Asset Management's 13F filing for Q4 2015, filed 3 Feb 2016.